Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types

NCT05907447 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT05907447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05907447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2023
Completion date
October 1, 2024
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic large cell lymphoma, angioimmunoblastic t-cell lymphoma, diffuse large b cell lymphoma, extranodal lymphoma, intravascular large b-cell lymphoma, lymphoma, marginal zone lymphoma, mucosa-associated lymphoid tissue lymphoma, nk/t-cell lymphoma, nasal and nasal-type